Literature DB >> 12114723

Pituitary Changes in Ataxia-Telangiectasia Syndrome: An Immunocytochemical, In Situ Hybridization, and DNA Cytometric Study of Three Cases.

Kalman Kovacs1, Caterina Giannini, Bernd W. Scheithauer, Lucia Stefaneanu, Ricardo V. Lloyd, Eva Horvath.   

Abstract

Ataxia-telangiectasia (AT) syndrome (cerebellar ataxia, oculocutaneous telangiectasias, immunodeficiency, susceptibility to infections, and neoplasia) is associated with cyto- and nucleomegaly in several organ systems. Our aim was to determine (1) whether such cellular abnormalities in the pituitary selectively involve specific cell types, and (2) the proliferation and DNA ploidy status of such cells. Three AT autopsy pituitaries were studied by histology, immunohistochemistry (pituitary hormones, MIB-1, p53 protein), in situ hybridization (pituitary hormones), and Feulgen stain image analysis for ploidy. Results indicated that, in adenohypophyses the scattered pleomorphic, bizarre nuclei were mainly those of somatotrophs and corticotrophs, growth hormone (GH), or adrenocorticotropic hormone (ACm) immunoreactive and expressing the GH or ACTH gene, respectively. Cyto- and nucleomegaly were less frequent in other secretory cells but were also noted in pituicytes of the posterior lobe. Affected cells were immunonegative for MIB-1 and for p53 protein. Image morphometric DNA analysis showed the bizarre cells to be aneuploid with complex histogram patterns, including many nuclei with DNA contents >8 n. No adenomas were found. We conclude that in AT adenohypophyseal cells with cyto- and nucleomegaly, as well as pleomorphism, synthesize and store adenohypophyseal hormones, mainly GH or ACTH. They and affected pituicytes are nonproliferative and are aneuploid.

Entities:  

Year:  1997        PMID: 12114723     DOI: 10.1007/bf02738786

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  37 in total

1.  p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.

Authors:  K Thapar; B W Scheithauer; K Kovacs; P J Pernicone; E R Laws
Journal:  Neurosurgery       Date:  1996-04       Impact factor: 4.654

2.  Effect of dopamine agonist medication on prolactin producing pituitary adenomas. A morphological study including immunocytochemistry, electron microscopy and in situ hybridization.

Authors:  K Kovacs; L Stefaneanu; E Horvath; R V Lloyd; I Lancranjan; M Buchfelder; R Fahlbusch
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

3.  Silent somatotroph adenomas of the human pituitary. A morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination, and in situ hybridization.

Authors:  K Kovacs; R Lloyd; E Horvath; S L Asa; L Stefaneanu; D W Killinger; H S Smyth
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

4.  Endocrinological studies in ataxiatelangiectasia and other immunological deficiency diseases.

Authors:  A J Ammann; R J Duquesnoy; R A Good
Journal:  Clin Exp Immunol       Date:  1970-04       Impact factor: 4.330

5.  Ataxia-telangiectasia. Its association with megalencephaly and mesenteric lymphangiectasia.

Authors:  R E Scott
Journal:  Arch Pathol       Date:  1969-07

Review 6.  Ataxia-telangiectasia: an interdisciplinary approach to pathogenesis.

Authors:  R A Gatti; E Boder; H V Vinters; R S Sparkes; A Norman; K Lange
Journal:  Medicine (Baltimore)       Date:  1991-03       Impact factor: 1.889

Review 7.  Ataxia-telangiectasia.

Authors:  R A Gatti
Journal:  Dermatol Clin       Date:  1995-01       Impact factor: 3.478

8.  Pituitary adenoma with neuronal choristoma (PANCH): composite lesion or lineage infidelity?

Authors:  E Horvath; K Kovacs; B W Scheithauer; R V Lloyd; H S Smyth
Journal:  Ultrastruct Pathol       Date:  1994 Nov-Dec       Impact factor: 1.094

9.  A single ataxia telangiectasia gene with a product similar to PI-3 kinase.

Authors:  K Savitsky; A Bar-Shira; S Gilad; G Rotman; Y Ziv; L Vanagaite; D A Tagle; S Smith; T Uziel; S Sfez; M Ashkenazi; I Pecker; M Frydman; R Harnik; S R Patanjali; A Simmons; G A Clines; A Sartiel; R A Gatti; L Chessa; O Sanal; M F Lavin; N G Jaspers; A M Taylor; C F Arlett; T Miki; S M Weissman; M Lovett; F S Collins; Y Shiloh
Journal:  Science       Date:  1995-06-23       Impact factor: 47.728

Review 10.  Ataxia telangiectasia genes and predisposition to leukaemia, lymphoma and breast cancer.

Authors:  A M Taylor
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

View more
  7 in total

1.  Undifferentiated sarcoma of the sellar region.

Authors:  Branavan Manoranjan; Luis V Syro; Bernd W Scheithauer; Leon D Ortiz; Eva Horvath; Fateme Salehi; Kalman Kovacs; Michael D Cusimano
Journal:  Endocr Pathol       Date:  2011-09       Impact factor: 3.943

2.  Endocrine abnormalities in ataxia telangiectasia: findings from a national cohort.

Authors:  Andreea Nissenkorn; Yael Levy-Shraga; Yonit Banet-Levi; Avishay Lahad; Ifat Sarouk; Dalit Modan-Moses
Journal:  Pediatr Res       Date:  2016-02-18       Impact factor: 3.756

3.  Pituitary adenoma with tumoral granulomatous reaction.

Authors:  Bernd W Scheithauer; Ana Isabel Silva; John L D Atkinson; Todd B Nippoldt; Timothy J Kaufmann; Kalman Kovacs; Eva Horvath; Ricardo Lloyd
Journal:  Endocr Pathol       Date:  2007       Impact factor: 3.943

Review 4.  Prognostic indicators in pituitary tumors.

Authors:  Agustinus Suhardja; Kalman Kovacs; Oded Greenberg; Bernd W Scheithauer; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2005       Impact factor: 4.056

5.  Linear growth and endocrine function in children with ataxia telangiectasia.

Authors:  Mohammad Ehlayel; Ashraf Soliman; Vincenzo De Sanctis
Journal:  Indian J Endocrinol Metab       Date:  2014-11

6.  The natural history of ataxia-telangiectasia (A-T): A systematic review.

Authors:  Emily Petley; Alexander Yule; Shaun Alexander; Shalini Ojha; William P Whitehouse
Journal:  PLoS One       Date:  2022-03-15       Impact factor: 3.752

7.  Body composition, muscle strength and hormonal status in patients with ataxia telangiectasia: a cohort study.

Authors:  H Pommerening; S van Dullemen; M Kieslich; R Schubert; S Zielen; S Voss
Journal:  Orphanet J Rare Dis       Date:  2015-12-09       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.